Paul Tudor Jones’s BioNTech BNTX Stock Holding History

Paul Tudor Jones’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,758	Closed	-$730K	–	3590
2026 Q1	$690K	Buy	7,758 +4,801	+162%	+$493K	﹤0.01%	2614
2025 Q4	$282K	Buy	+2,957	New	+$298K	﹤0.01%	3093
2023 Q4	–	Sell	-2,934	Closed	-$319K	–	2389
2023 Q3	$319K	Buy	+2,934	New	+$324K	﹤0.01%	1904
2023 Q1	–	Sell	-5,123	Closed	-$770K	–	2426
2022 Q4	$770K	Buy	+5,123	New	+$788K	0.02%	1297
2022 Q3	–	Sell	-2,257	Closed	-$337K	–	2316
2022 Q2	$337K	Buy	+2,257	New	+$345K	0.01%	1489
2021 Q4	–	Sell	-1,853	Closed	-$506K	–	2409
2021 Q3	$506K	Buy	+1,853	New	+$589K	0.01%	1639
2021 Q2	–	Sell	-5,046	Closed	-$551K	–	1617
2021 Q1	$551K	Buy	+5,046	New	+$536K	0.01%	1103

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Paul Tudor Jones's BNTX Position: Q2 2026 in Review

Paul Tudor Jones sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 7,758 shares — an estimated $730K sold.

Paul Tudor Jones first reported a position in BNTX in Q1 2021 and held it in 7 quarters. The position peaked at $770K in Q4 2022. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Paul Tudor Jones reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 7,758 BioNTech shares in Q2 2026, an estimated $730K.
Paul Tudor Jones first reported a position in BioNTech in Q1 2021 and held it in 7 quarters.
Paul Tudor Jones's BioNTech position peaked at $770K in Q4 2022.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.